Higher levels of income inequality in youth are associated with increased ‘deaths of despair’ in young Canadians.
L’expertise universitaire, l’exigence journalistique
Articles sur Opioid crisis
Affichage de 1 à 20 de 80 articles
The Pulitzer Prize-winning author is just one of many artists from Appalachia who are probing the crisis in their work, while taking pains to ensure that it doesn’t define the region and its people.
Decriminalization helps recharacterize drug addiction as a chronic health condition instead of a criminal activity, reduces the stigma associated with drug use and improves treatment options.
As British Columbia begins a new era in drug policy, the drug poisoning crisis continues without an end in sight.
More than 50 overdoses happen in bathrooms every month in British Columbia. Public bathrooms can be made safer for everyone, including people who use substances.
Making them pay is important but it’s not going to stop drugmakers from endangering public health.
The Purdue Pharma settlement is paltry compared to costs of the opioid crisis. Without major changes to pharma industry regulation, there is little reason to think a similar crisis won’t occur again.
British Columbia’s bold experiment provides an opportunity to implement more balance in Canadian drug policy, and a more principled withdrawal from the war on drugs.
Non-opioid directives allow patients to refuse opioids in all health care settings. For surgical procedures that require anesthesia, however, this may do more harm than good.
Game making is an art form that many aren’t intimately familiar with. Unlike other creative practices, game makers must create the rules and laws that govern and shape player behaviours.
Measures to curb growing rates of opioid use are also making it difficult for people with long-term, chronic pain to get ongoing prescriptions.
People are dying from using a toxic drug supply. Safer supply and other approaches that listen to the needs of people who use drugs are critical to saving lives and addressing the opioid crisis.
Drug manufacturers often shun the use of placebos in clinical trials. But research suggests that placebos could play an important role in the treatment of depression, pain and other maladies.
The number of fatal drug overdoses in the US over a 12-month period has surpassed 100,000 for the first time. Fentanyl is the main driver of the spike in deaths.
False narratives about drug addiction and policies that are not supported by research are deepening the overdose epidemic in the US.
The multibillion-dollar settlement will trigger the release of troves of documents that may shine new light on what caused the opioid crisis.
Ending the opioid epidemic requires addressing not only treatment gaps in addiction and overdose, but also inadequate pain management.
Fentanyl adulteration led to the replacement of heroin in the unregulated drug supply of British Columbia. Now that benzodiazepines are present in many opioids, are we headed towards a ‘new normal?’
Decriminalization is an important step in addressing the overdose crisis, but it is crucial that other approaches — like regulation — are also in place.
The start of one new public health crisis didn’t mean the end of another.
Les contributeurs les plus fréquents
-
Professor Emeritus of Health Policy and Management, York University, Canada
-
Associate Professor of History, University at Buffalo
-
Professor and Deputy Director, Monash Addiction Research Centre, Monash University
-
Medical Director of Opioid Policy Research, Brandeis University
-
Professor, Head of Department of Medicine, Queen's University, Ontario
-
Visiting Assistant Professor of Sociology, College of the Holy Cross
-
Professor of Law, Indiana University
-
PhD Candidate, School of Nursing, University of British Columbia
-
PhD Student, School of Population and Public Health, University of British Columbia
-
Co-Director, Opioid Prescribing Engagement Network and Assistant Professor, University of Michigan
-
Professor of Clinical Neurosciences and Foundation Chair in Physiotherapy, University of South Australia
-
PhD Candidate, National Drug and Alcohol Research Centre, UNSW Sydney
-
Associate Professor of Population Health, New York University
-
Associate Professor of Public Health and Community Medicine; Weiner Hailey Family Professor, Tufts University
-
Assistant Professor of Hip-Hop, University of Virginia
